Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Exchange Rate Effect (2020 - 2025)

Bioventus (BVS) has disclosed Exchange Rate Effect for 6 consecutive years, with $133000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Exchange Rate Effect rose 106.45% year-over-year to $133000.0, compared with a TTM value of $371000.0 through Dec 2025, up 114.49%, and an annual FY2025 reading of $371000.0, up 114.49% over the prior year.
  • Exchange Rate Effect was $133000.0 for Q4 2025 at Bioventus, up from -$394000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $1.1 million in Q4 2022 and bottomed at -$2.1 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is -$63350.0, with a median of -$10500.0 recorded in 2021.
  • The sharpest move saw Exchange Rate Effect soared 749.3% in 2023, then plummeted 660.6% in 2024.
  • Year by year, Exchange Rate Effect stood at $149000.0 in 2021, then soared by 606.04% to $1.1 million in 2022, then plummeted by 65.02% to $368000.0 in 2023, then tumbled by 660.6% to -$2.1 million in 2024, then surged by 106.45% to $133000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for BVS at $133000.0 in Q4 2025, -$394000.0 in Q3 2025, and $202000.0 in Q2 2025.